Today is May 12, 2024.
All times in Eastern Daylight Time.
-
Nerdy to Participate in J.P. Morgan Conference
ST. LOUIS--(BUSINESS WIRE)--Nerdy Inc. (NYSE: NRDY), a leading platform for delivering live online learning, today announced that management will participate in a fireside chat at the J.P. Morgan G... more »
-
Green Dot Reports First Quarter 2024 Results
AUSTIN, Texas--(BUSINESS WIRE)--Green Dot Corporation (NYSE: GDOT), a leading digital bank and fintech that delivers seamless banking and payment tools for consumers and businesses, today reported ... more »
-
CareDx Reports First Quarter 2024 Results
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Reported first quarter re... more »
-
TechTarget Reports First Quarter 2024 Conference Call and Webcast
NEWTON, Mass.--(BUSINESS WIRE)--TechTarget, Inc. (Nasdaq: TTGT) today announced financial results for the three (3) months ended March 31, 2024 by posting them to our website. more »
-
Dropbox Announces Fiscal 2024 First Quarter Results
SAN FRANCISCO--(BUSINESS WIRE)--Dropbox, Inc. (NASDAQ: DBX), today announced financial results for its first quarter ended March 31, 2024. “In Q1, our core business delivered in-line revenue and be... more »
-
Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced business updates and reported f... more »
-
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights
SAN DIEGO--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP), a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care canc... more »
-
Leafly Holdings, Inc. Reports First Quarter 2024 Financial Results
SEATTLE--(BUSINESS WIRE)--Leafly Holdings, Inc. (“Leafly” or “the Company”) (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced fina... more »
-
Lantern Pharma Reports First Quarter 2024 Financial Results and Business Highlights
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR® AI and mac... more »
-
MindMed to Participate at May Investor Conferences
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain he... more »
-
Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announce... more »
-
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
LA JOLLA, Calif.--(BUSINESS WIRE)--Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe... more »
-
Ross Stores, Inc. Announces First Quarter 2024 Earnings Release and Conference Call
DUBLIN, Calif.--(BUSINESS WIRE)--Ross Stores, Inc. (NASDAQ: ROST) plans to release its first quarter 2024 earnings results on Thursday, May 23, 2024 at approximately 4:00 p.m. Eastern time. Partici... more »
-
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical need... more »
-
Everbridge Announces First Quarter 2024 Financial Results
BURLINGTON, Mass.--(BUSINESS WIRE)--Everbridge, Inc. (Nasdaq: EVBG), the global leader in critical event management (CEM) and national public warning solutions, today announced its financial result... more »
-
GAN Reports First Quarter 2024 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--GAN Limited (NASDAQ: GAN) (the “Company” or “GAN”), a leading North American B2B technology provider of real money internet gaming solutions and a leading Internati... more »
-
Quantum-Si Reports First Quarter 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the first quar... more »
-
Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to dev... more »
-
Cutera Announces First Quarter 2024 Financial Results
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today reported financial results for the first... more »
-
Franklin Resources, Inc. Announces Month-End Assets Under Management
SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Resources, Inc. (Franklin Templeton) (NYSE: BEN) today reported preliminary month-end assets under management (AUM) of $1.60 trillion at April 30, 2024,... more »
-
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
RICHMOND, Calif.--(BUSINESS WIRE)--SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS more »
-
Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 second quarter ended March 31, 2024. The Company is hosting a... more »
-
Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in im... more »
-
Arcellx Provides First Quarter 2024 Financial Results
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer ... more »
-
Expensify Announces Q1 2024 Results
PORTLAND, Ore.--(BUSINESS WIRE)--Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corpo... more »
|
|